Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Trellis Bioscience

Facebook Twitter LinkedIn Email Comments
Trellis Bioscience of South San Francisco has partnered with PDL BioPharma Inc. of Fremont, Calif. Under the terms of the agreement, the former will use its CellSpot technology to search for monoclonal antibodies directed against an antigen from the latter, which will conduct further research on the antibodies found. The device combines software and digital microscopy to simultaneously analyze cells along more than 15 parameters. Trellis will receive an upfront fee, milestone payments and royalties on any products developed and commercialized by PDL.

BioPhotonics
Apr 2007
antibodiesBiophotonicsMicroscopyNews & FeaturesPDL BioPharma Inc.Trellis Bioscience

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.